These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10419049)

  • 1. Tumor-suppressive activity of CD66a in prostate cancer.
    Luo W; Tapolsky M; Earley K; Wood CG; Wilson DR; Logothetis CJ; Lin SH
    Cancer Gene Ther; 1999; 6(4):313-21. PubMed ID: 10419049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of a tumor suppressor (C-CAM1)-expressing recombinant adenovirus in androgen-independent human prostate cancer therapy: a preclinical study.
    Kleinerman DI; Zhang WW; Lin SH; Nguyen TV; von Eschenbach AC; Hsieh JT
    Cancer Res; 1995 Jul; 55(13):2831-6. PubMed ID: 7796410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice.
    Lee J; Wang A; Hu Q; Lu S; Dong Z
    Int J Oncol; 2006 Dec; 29(6):1405-12. PubMed ID: 17088978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function and therapeutic implication of C-CAM cell-adhesion molecule in prostate cancer.
    Lin SH; Pu YS
    Semin Oncol; 1999 Apr; 26(2):227-33. PubMed ID: 10597733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of the 16-kDa prolactin fragment in prostate cancer.
    Kim J; Luo W; Chen DT; Earley K; Tunstead J; Yu-Lee LY; Lin SH
    Cancer Res; 2003 Jan; 63(2):386-93. PubMed ID: 12543792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schedule-dependence of C-CAM1 adenovirus gene therapy in a prostate cancer model.
    Lin SH; Pu YS; Luo W; Wang Y; Logothetis CJ
    Anticancer Res; 1999; 19(1A):337-40. PubMed ID: 10226564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD66a (human C-CAM) and other members of the carcinoembryonic antigen gene family of adhesion molecules in human colorectal adenomas.
    Nollau P; Scheller H; Kona-Horstmann M; Rohde S; Hagenmüller F; Wagener C; Neumaier M
    Cancer Res; 1997 Jun; 57(12):2354-7. PubMed ID: 9192807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
    Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW
    Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
    Igawa T; Lin FF; Rao P; Lin MF
    Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of the glucocorticoid response during Ad5IL-12 adenovirus vector treatment enhances natural killer cell-mediated killing of MHC class I-negative LNCaP prostate tumors.
    Raja Gabaglia C; Diaz de Durana Y; Graham FL; Gauldie J; Sercarz EE; Braciak TA
    Cancer Res; 2007 Mar; 67(5):2290-7. PubMed ID: 17332360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoviral vector containing wild-type p16 suppresses prostate cancer growth and prolongs survival by inducing cell senescence.
    Steiner MS; Zhang Y; Farooq F; Lerner J; Wang Y; Lu Y
    Cancer Gene Ther; 2000 Mar; 7(3):360-72. PubMed ID: 10766342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cytoplasmic domain of C-CAM1 tumor suppressor is necessary and sufficient for suppressing the tumorigenicity of prostate cancer cells.
    Estrera VT; Luo W; Phan D; Earley K; Hixson DC; Lin SH
    Biochem Biophys Res Commun; 1999 Oct; 263(3):797-803. PubMed ID: 10512760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective induction of cell cycle arrest and apoptosis in human prostate cancer cells through adenoviral transfer of the melanoma differentiation-associated -7 (mda-7)/interleukin-24 (IL-24) gene.
    Saito Y; Miyahara R; Gopalan B; Litvak A; Inoue S; Shanker M; Branch CD; Mhashilkar AM; Roth JA; Chada S; Ramesh R
    Cancer Gene Ther; 2005 Mar; 12(3):238-47. PubMed ID: 15578066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.
    Lowe SL; Rubinchik S; Honda T; McDonnell TJ; Dong JY; Norris JS
    Gene Ther; 2001 Sep; 8(18):1363-71. PubMed ID: 11571575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated expression of CD66a (BGP, C-CAM), an adhesion molecule of the CEA family, in endometrial cancer.
    Bamberger AM; Riethdorf L; Nollau P; Naumann M; Erdmann I; Götze J; Brümmer J; Schulte HM; Wagener C; Löning T
    Am J Pathol; 1998 Jun; 152(6):1401-6. PubMed ID: 9626043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated delivery of human IFNgamma gene inhibits prostate cancer growth.
    Zhao P; Zhu YH; Wu JX; Liu RY; Zhu XY; Xiao X; Li HL; Huang BJ; Xie FJ; Chen JM; Ke ML; Huang W
    Life Sci; 2007 Aug; 81(9):695-701. PubMed ID: 17714738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function.
    Izzi L; Turbide C; Houde C; Kunath T; Beauchemin N
    Oncogene; 1999 Sep; 18(40):5563-72. PubMed ID: 10523833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of prostate tumor growth by overexpression of NudC, a microtubule motor-associated protein.
    Lin SH; Nishino M; Luo W; Aumais JP; Galfione M; Kuang J; Yu-Lee LY
    Oncogene; 2004 Apr; 23(14):2499-506. PubMed ID: 14676831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for the WWOX gene in prostate cancer.
    Qin HR; Iliopoulos D; Semba S; Fabbri M; Druck T; Volinia S; Croce CM; Morrison CD; Klein RD; Huebner K
    Cancer Res; 2006 Jul; 66(13):6477-81. PubMed ID: 16818616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis.
    Matsubara S; Wada Y; Gardner TA; Egawa M; Park MS; Hsieh CL; Zhau HE; Kao C; Kamidono S; Gillenwater JY; Chung LW
    Cancer Res; 2001 Aug; 61(16):6012-9. PubMed ID: 11507044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.